Novome Biotechnologies的封面图片
Novome Biotechnologies

Novome Biotechnologies

生物技术研究

South San Francisco,CA 3,705 位关注者

Engineering Living Medicines for Chronic Diseases

关于我们

Novome is building genetically engineered microbial medicines (GEMMs) that perform defined activities in the human gut to treat chronic diseases. We have developed the first platform for controlled colonization of the gut with engineered therapeutic bacteria, and are applying this to multiple disease areas as well as expanding our platform capabilities. Our lead program in enteric hyperoxaluria is currently in Phase 2 clinical trials, and we are focusing current research efforts on making a microbial cell therapy to treat inflammatory bowel disease (IBD).

网站
https://novomebio.com
所属行业
生物技术研究
规模
11-50 人
总部
South San Francisco,CA
类型
私人持股
创立
2016
领域
Microbiome、Synthetic Biology和Therapeutics

地点

  • 主要

    279 E Grand Ave

    US,CA,South San Francisco,94080

    获取路线

Novome Biotechnologies员工

相似主页

查看职位

融资